MRNA earnings
Moderna (MRNA) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- MRNA reports next on Feb 12, 2027, with EPS of -2.07 expected.
- MRNA beat EPS estimates in 13 of its last 16 reports.
MRNA earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 6, 2026 | 0.38 | -1.10 | 134.55% | $1.31B |
| Q2 2026 | Jul 31, 2026 | -1.97 | -2.03 | 2.96% | $145.00M |
| Q1 2026 | May 1, 2026 | -3.40 | -4.45 | 23.60% | $389.00M |
| Q4 2025 | Feb 13, 2026 | -2.11 | -2.54 | 16.93% | $678.00M |
| Q3 2025 | Nov 6, 2025 | -0.51 | -1.87 | 72.73% | $1.02B |
| Q2 2025 | Aug 1, 2025 | -2.13 | – | – | $142.00M |
| Q1 2025 | May 1, 2025 | -2.52 | -2.92 | 13.70% | $108.00M |
| Q4 2024 | Feb 14, 2025 | -2.50 | -2.68 | 6.72% | $966.00M |
| Q3 2024 | Nov 7, 2024 | 0.03 | -1.91 | 101.57% | $1.86B |
| Q2 2024 | Aug 1, 2024 | -3.33 | -3.35 | 0.60% | $241.00M |
| Q1 2024 | May 2, 2024 | -3.07 | -3.56 | 13.76% | $167.00M |
| Q4 2023 | Feb 22, 2024 | 0.55 | -0.97 | 156.70% | $2.81B |
| Q3 2023 | Nov 2, 2023 | -9.53 | -1.93 | -393.19% | $1.83B |
| Q2 2023 | Aug 3, 2023 | -3.62 | -3.84 | 5.73% | $344.00M |
| Q1 2023 | May 4, 2023 | 0.19 | -1.77 | 110.73% | $1.86B |
| Q4 2022 | Feb 23, 2023 | 3.61 | 4.68 | -22.86% | $5.08B |
| Q3 2022 | Nov 3, 2022 | 2.53 | 3.29 | -23.10% | $3.36B |